相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat
Thomas K. Sears et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
Visualizing and interpreting cancer genomics data via the Xena platform
Mary J. Goldman et al.
NATURE BIOTECHNOLOGY (2020)
CRISPR Editing of Mutant IDH1 R132H Induces a CpG Methylation-Low State in Patient-Derived Glioma Models of G-CIMP
Casey J. Moure et al.
MOLECULAR CANCER RESEARCH (2019)
Integrated molecular characterization of IDH-mutant glioblastomas
A. Korshunov et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2019)
Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors
Jeremy Lewin et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma
Liang Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Isocitrate dehydrogenase 1 mutation sensitizes intrahepatic cholangiocarcinoma to the BET inhibitor JQ1
Hiroaki Fujiwara et al.
CANCER SCIENCE (2018)
Bromodomain Histone Readers and Cancer
Abhinav K. Jain et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
Transcription elongation factors represent in vivo cancer dependencies in glioblastoma
Tyler E. Miller et al.
NATURE (2017)
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1
Tali Mazor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Insulator dysfunction and oncogene activation in IDH mutant gliomas
William A. Flavahan et al.
NATURE (2016)
Integrated genomic characterization of IDH1-mutant glioma malignant progression
Hanwen Bai et al.
NATURE GENETICS (2016)
The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins
Yasushi Taniguchi
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Dose optimization of MK-8628 (OTX015), a small molecule inhibitor of bromodomain and extra-terminal (BET) proteins, in patients (pts) with recurrent glioblastoma (GB)
Andreas Felix Hottinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Nanog Requires BRD4 to Maintain Murine Embryonic Stem Cell Pluripotency and Is Suppressed by Bromodomain Inhibitor JQ1 Together with Lefty1
Gillian A. Horne et al.
STEM CELLS AND DEVELOPMENT (2015)
Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells
Chad M. Toledo et al.
CELL REPORTS (2015)
The BET Family Member BRD4 Interacts with OCT4 and Regulates Pluripotency Gene Expression
Tao Wu et al.
STEM CELL REPORTS (2015)
BET Bromodomain Blockade Mitigates Intimal Hyperplasia in Rat Carotid Arteries
Bowen Wang et al.
EBIOMEDICINE (2015)
BET bromodomain proteins are required for glioblastoma cell proliferation
Chiara Pastori et al.
EPIGENETICS (2014)
Inducible In Vivo Silencing of Brd4 Identifies Potential Toxicities of Sustained BET Protein Inhibition
Jessica E. Bolden et al.
CELL REPORTS (2014)
Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma
Zhixiang Cheng et al.
CLINICAL CANCER RESEARCH (2013)
BET Protein Function Is Required for Inflammation: Brd2 Genetic Disruption and BET Inhibitor JQ1 Impair Mouse Macrophage Inflammatory Responses
Anna C. Belkina et al.
JOURNAL OF IMMUNOLOGY (2013)
cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome
Yazmin Odia et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells
Krishanpal Karmodiya et al.
BMC GENOMICS (2012)
An in vivo patient-derived model of endogenous IDH1-mutant glioma
H. Artee Luchman et al.
NEURO-ONCOLOGY (2012)
Histone Demethylase Jumonji D3 (JMJD3) as a Tumor Suppressor by Regulating p53 Protein Nuclear Stabilization
Chibawanye I. Ene et al.
PLOS ONE (2012)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Histone H3K27ac separates active from poised enhancers and predicts developmental state
Menno P. Creyghton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
14-3-3 Mediates Histone Cross-Talk during Transcription Elongation in Drosophila
Caline S. Karam et al.
PLOS GENETICS (2010)
Histone Crosstalk between H3S10ph and H4K16ac Generates a Histone Code that Mediates Transcription Elongation
Alessio Zippo et al.
CELL (2009)
SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma
Myung Jin Son et al.
CELL STEM CELL (2009)
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Marc Sanson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
分享论文
